This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazzarotto, T.
Right arrow Articles by Landini, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazzarotto, T.
Right arrow Articles by Landini, M. P.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 1999, p. 127-129, Vol. 6, No. 1
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Anticytomegalovirus (Anti-CMV) Immunoglobulin G Avidity in Identification of Pregnant Women at Risk of Transmitting Congenital CMV Infection

Tiziana Lazzarotto,1 Patrizia Spezzacatena,1 Stefania Varani,1 Liliana Gabrielli,1 Paola Pradelli,1 Brunella Guerra,2 and Maria Paola Landini1,*

Department of Clinical and Experimental Medicine, Section of Microbiology1 and Second Department of Obstetrics and Gynecology,2 Medical School, University of Bologna, Bologna, Italy

Received 6 July 1998/Returned for modification 17 August 1998/Accepted 30 September 1998

In this work, we show that the determination of the anticytomegalovirus antibody avidity carried out before week 18 of gestation is a helpful tool to identify women for enrollment in prenatal diagnosis. This procedure can identify all pregnant women who will give birth to an infected newborn.


* Corresponding author. Mailing address: Dipartimento di Medicina Clinica Specialistica e Sperimentale, Sezione di Microbiologia, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy. Phone: 39.051.341652. Fax: 39.051.341632. E-mail: viroland{at}med.unibo.it.


Clinical and Diagnostic Laboratory Immunology, January 1999, p. 127-129, Vol. 6, No. 1
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Revello, M. G., Gerna, G. (2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev. 15: 680-715 [Abstract] [Full Text]  
  • Sipewa, M. J., Goubau, P., Bodeus, M. (2002). Evaluation of a Cytomegalovirus Glycoprotein B Recombinant Enzyme Immunoassay To Discriminate between a Recent and a Past Infection. J. Clin. Microbiol. 40: 3689-3693 [Abstract] [Full Text]  
  • Prince, H. E., Leber, A. L. (2002). Validation of an In-House Assay for Cytomegalovirus Immunoglobulin G (CMV IgG) Avidity and Relationship of Avidity to CMV IgM Levels. CVI 9: 824-827 [Abstract] [Full Text]  
  • Baccard-Longere, M., Freymuth, F., Cointe, D., Seigneurin, J. M., Grangeot-Keros, L. (2001). Multicenter Evaluation of a Rapid and Convenient Method for Determination of Cytomegalovirus Immunoglobulin G Avidity. CVI 8: 429-431 [Abstract] [Full Text]  
  • Lazzarotto, T., Varani, S., Gabrielli, L., Pignatelli, S., Landini, M. P. (2001). The tegument protein ppUL25 of human cytomegalovirus (CMV) is a major target antigen for the anti-CMV antibody response. J. Gen. Virol. 82: 335-338 [Abstract] [Full Text]  
  • Lazzarotto, T., Galli, C., Pulvirenti, R., Rescaldani, R., Vezzo, R., La Gioia, A., Martinelli, C., La Rocca, S., Agresti, G., Grillner, L., Nordin, M., van Ranst, M., Combs, B., Maine, G. T., Landini, M. P. (2001). Evaluation of the Abbott AxSYM Cytomegalovirus (CMV) Immunoglobulin M (IgM) Assay in Conjunction with Other CMV IgM Tests and a CMV IgG Avidity Assay. CVI 8: 196-198 [Abstract] [Full Text]